Clinical Trials Directory

Trials / Unknown

UnknownNCT02391168

Fatty Liver Disease Collaborative Research in China

A Multi-center, Prospective Cohort Study on the Natural History of Fatty Liver Disease in China

Status
Unknown
Phase
Study type
Observational
Enrollment
3,000 (estimated)
Sponsor
Fatty Liver and Alcoholic Liver Disease Study Group, China · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

A multi-center, prospective cohort study on the natural history of fatty liver disease in China

Detailed description

This is a multicenter, prospective and open-enrollment epidemiologic study. All the patients with liver biopsy-proven macrovesicular steatosis (\>5%) will be enrolled in the baseline cross-sectional analysis. Those who are either diagnosed as NAFLD or ALD, if meeting all the inclusion and exclusion criteria, will be enrolled in the following cohort study, will be followed up after 1 year, 3 years and 5 years with a visit window of +1 month.

Conditions

Timeline

Start date
2015-07-01
Primary completion
2020-12-01
Completion
2020-12-01
First posted
2015-03-18
Last updated
2015-08-05

Locations

6 sites across 1 country: China

Source: ClinicalTrials.gov record NCT02391168. Inclusion in this directory is not an endorsement.